Drug intelligence / Profile preview

Urimenna

Development stage
Unknown
Lead developer
Kéri Pharma
Modality
Small Molecules
Administration
Oral
01

Overview

Urimenna is a multi-ingredient dietary supplement developed by Kéri Pharma Hungary, specifically designed to support healthy urinary tract function and alleviate symptoms associated with urinary tract infections (UTIs). Formulated as wild berry-flavored, orally soluble granules, it contains seven active ingredients, including D-mannose, cranberry extract (*Vaccinium macrocarpon*), goldenrod extract (*Solidago virgaurea*), and vitamins A and C. D-mannose and cranberry extracts are utilized for their ability to inhibit the adhesion of *Escherichia coli* to the urinary tract walls, while goldenrod supports normal bladder and lower urinary tract function. Vitamins A and C are included to bolster the immune system and maintain the integrity of mucous membranes. The product is specifically positioned for the prevention and supportive treatment of recurrent UTIs.

Brand names
Urimenna
Other names
Urimenna granulátum
02

Targets

MRC1 (Mannose Receptor C-type 1)

Beyond the preview

Go deeper on Urimenna.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Urimenna.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call